Key PointsShares of Shein plunged up to 10% in Hong Kong trading following urgent recalls of contaminated contact lenses in two countries.Testing revealed the presence of Burkholderia cepacia complex bacteria in the solution packaging the contact lenses.The bacterial contamination was detected in the lens solution rather than the lenses directly.One case of eye infection connected to the product has been documented in the United Kingdom.This product safety crisis compounds challenges for Shein after its turbulent Hong Kong market listing.Shein stock experienced a sharp decline of up to 10% during Monday’s Hong Kong trading session after regulatory authorities in Australia and New Zealand ordered immediate recalls of contact lens products sold through its platform.The Hong Kong-listed shares (625-HK) were down 9.49% at HK$36.26 during the reporting period.Regulatory action was initiated after laboratory testing identified Burkholderia cepacia complex bacteria in samples, with the contamination traced to the solution used for packaging the contact lenses.Shein shares fall 10% amid urgent recall of contact-lens cleaner by Australia, New Zealand https://t.co/Vw7OrKenwL— CNBC (@CNBC) September 14, 2026On Friday, New Zealand’s Ministry of Business Innovation and Employment verified the contamination, issuing warnings that bacterial exposure presents risks of eye infections and irritation to consumers.Authorities highlighted that at least one adverse event had occurred in the United Kingdom, where a consumer contracted an eye infection traced back to these contact lenses.Australia’s Competition and Consumer Commission released a comparable recall advisory simultaneously.The timing proves particularly problematic for the fast-fashion giant. Following an unstable Hong Kong stock exchange launch earlier this month, Shein was already grappling with fragile investor sentiment.Challenges Intensify Following Rocky Market EntryThe retailer’s operational model confronts mounting obstacles across major Western territories. Tariff implementations and evolving regulatory frameworks in European and American markets threaten the discount-focused strategy that propelled Shein to international prominence.Research from Euromonitor International indicates Shein must evolve beyond its traditional emphasis on low prices and rapid inventory turnover. Recommendations include improving marketplace curation and broadening service offerings.Corporate reputation has become increasingly vulnerable. Government agencies and consumer advocacy groups across multiple jurisdictions have intensified their examination of the company’s practices.This recall introduces product safety liabilities to existing concerns, representing unfamiliar territory for an enterprise predominantly associated with apparel merchandise.Investment Implications of the RecallThe substantial intraday decline demonstrates market volatility surrounding equity that entered trading with considerable uncertainty.Shein’s diversification into beauty and lifestyle merchandise formed part of its comprehensive marketplace expansion strategy. Safety failures in this segment, particularly involving ocular health, generate more severe market reactions than conventional supply chain disruptions or pricing controversies.The regulatory action impacts merchandise distributed via Shein’s platform throughout Australia and New Zealand, with officials instructing consumers to cease use immediately and arrange product returns.As of publication, Shein had not released an official statement addressing the recalls.The post Shein Stock Plunges 10% Following Bacterial Contamination in Contact Lenses appeared first on Blockonomi.